New Animal Study Of Rexahn's Serdaxinâ„¢ Shows Drug's Promise To Treat Anxiety And Depression With Minimal Side Effects | Psydir News
Links shared publicly online about this topic.
- 1,963total visits
New Animal Study Of Rexahn's Serdaxinâ„¢ Shows Drug's Promise To Treat Anxiety And Depression With Minimal Side Effects | Psydir News
Rexahn pharmaceuticals, inc. (nyse amex: rnn), announced the results of a wide-ranging animal study offering more evidence that serdaxinâ„¢ may be an effective therapeutic for the treatment of anxiety disorders in humans. serdaxin is rexahn's leading anxiety and depression drug candidate, and is currently in phase ii clinical trials.
View full resource at news.psydir.com
Tags: Anxiety Disorder, Anxiety, Depression, Drug, Pharma, News, Nature
Most Recently Shared on June 17, 2009 at 5:07 pm By:
New Animal Study Of Rexahn's Serdaxinâ„¢ Shows Drug's Promise To Treat Anxiety And Depression With Minimal Side Ef.. http://bit.ly/8Gxwx
Advertisement
